Desogen Tablets

Ethinyl estradiol and desogestrel are used together as combined oral contraceptives (COC). Ethinyl estradiol is a potent, synthetic estrogen. Desogestrel is a third-generation progestin with lowered androgenic effects and relatively no estrogenic action compared to older progestins. Thus desogestrel may have positive influences on acne, fluid retention, and lipid profiles. Combined hormonal contraceptives can be used in female patients from menarche to those over the age of 40 years up until the time of menopause with a proper selection of products. The choice of a routine hormonal contraceptive for any given patient is based on the individual’s contraceptive needs, underlying medical conditions or risk factors for adverse effects, and individual preferences for use. All combined oral contraceptives (COCs) have risks related to venous and arterial thromboembolism, particularly in women who smoke; all combined hormonal contraceptive labels contain a boxed warning about tobacco smoking. The Centers for Disease Control’s U.S. Medical Eligibility Criteria describe considerations for risk vs. benefits, including medical conditions or attributes that contraindicate use; these criteria can help to prescribe practitioners in product selection for individual patients.1 Contraceptive products containing ethinyl estradiol/desogestrel were initially FDA approved in 1992.2 Some products provide a reduced hormone-free interval in the cycle, which may be advantageous for patients experiencing migraines, dysmenorrhea, or other symptoms during the days they do not take active hormones